AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

Choosing the right method for multimodal AI—systems that combine text, images, and more—has long been trial and error. Emory ...

The earliest stage of drug discovery is governed by a simple constraint: there are far more possible drug-like molecules than any pharmaceutical laboratory could ever test. A new deep learning system, ...

A clear understanding of the fundamentals of ML improves the quality of explanations in interviews.Practical knowledge of Python libraries can be ...

Immunis, Inc., a clinical-stage biotech company targeting age-related diseases, today announced it has entered an exclusive licensing agreement with Toray to develop and commercialize a drug candidate ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

Systematic human inspection of the millions of source cutouts in the Hubble Legacy Archive is impossible – but artificial ...

Tenaya leverages “human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) with high-throughput in vitro screening, imaging analysis, and machine learning algorithms” to identify new ...

Companies are using AI to filter research results, and professionals are using AI to polish their resumes. Here's how you can ...

Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...

Those that solve artificially simplified problems where quantum advantage is meaningless. Those that provide no genuine quantum advantage when all costs are properly accounted for. This critique is ...

Recent media coverage highlights the wide range of research, education, and scientific perspectives emerging from the SETI Institute community. From teacher training programs that connect educators ...